Fierce Pharma
The Trinity Annual Drug Index was featured in an article by Fierce Pharma:
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, according to the latest edition of Trinity Life Sciences’ annual Drug Index—a trio of factors that explain how argenx’s Vyvgart beat out dozens of other drugs and biologics approved by the FDA in 2021 to be named that year’s strongest launch.
Read More…
Read Now
MM+M
Leslie Orne was named as one the MM+M 2025 Pinnacle Award honorees. Read the article to learn more.
Read now…
Read Now
PharmaVoice
Nancy Phelan, Senior Vice President and Head of Customer Engagement, was featured in an article in PharmaVoice discussing the upcoming CRM split: “A lot of leaders are starting to realize this is a much bigger decision, and they need to think through the choices, the timing and the approach to set up for a very different world.”
Read the article to learn more.
Read now…
Read Now
Pharmaceutical Executive
Trinity’s Monica Martin de Bustamante, Senior Partner & Head of Advisory, spoke with Pharmaceutical Executive about the Inflation Reduction Act and how companies are attempting to strategize around the uncertainty of upcoming pricing negotiations. Read the article to learn more.
Read Now…
Read Now
Marketing & Pharma
“Now is the right time for organizations to step back and say ‘what do we need organizationally to make the very valuable in-person engagement, whether it’s from a rep, medical science liaison, nurse educator or whomever, how do we set them up for success and help them show up as relevant, useful and fully compliant,” Nancy Phelan, Senior Vice President & Head of Customer Engagement
Read more from Nancy and other industry leaders in Marketing & Pharma’s article, “Pharma sales…
Read Now
Scrip
Trinity Life Sciences’ President and CEO, Leslie Orne, was quoted in an article by Scrip on the state of the biopharma industry in 2025.
Read Now…
Read Now
Marketing & Pharma
Trinity Life Sciences’ Jerry Luciano and Tim McLaughlin were featured in an article by Marketing & Pharma titled, “AZ and Pfizer top list of best digital pharma marketers, but other brands closing in: study.” The article focuses on the findings of the fourth annual TGaS Digital Marketing Competency Report. Read the article to learn more.
Read Now…
Read Now
Pharmaceutical Executive
Check out Pharmaceutical Executive’s article entitled, “Trinity Life Sciences Releases Annual TGaS Digital Marketing Competency Report” to learn more about our annual TGaS Digital Marketing Competency Report:
Read Now…
Read Now
MM+M
Trinity’s Jerry Luciano and Tim McLaughlin were featured in an article by MM+M titled, “Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report.” The article focuses on the findings of the fourth annual TGaS Digital Marketing Competency Report. Read the article to learn more.
Read Now…
Read Now
Investors Hangout
Trinity Life Sciences’ fourth annual TGaS Digital Marketing Competency Report was featured in an article published on Investors Hangout.
Read Now…
Read Now
